EGFR and non-small cell lung carcinoma: In 2016, a systematic review and meta-analysis was done to detect the prevalence of EGFR mutation in patients with non-small cell lung cancer by Zhang, et al. In this study a total of 456 studies were included, reporting 30,466 patients with EGFR mutations among 115,815 NSCLC patients.